chemotherapy
Showing 26 - 50 of 424
Checkpoint Inhibitors in Triple Negative Breast
Recruiting
- Triple Negative Breast Cancer
- Whole Genome Sequencing
- +7 more
-
Barcelona, SpainVall d'Hebron Institute of Oncology
Jun 20, 2023
NSCLC Metastatic Trial in Chengdu (Camrelizumab, stereotactic body radiation therapy, Chemotherapy)
Recruiting
- Non-small Cell Lung Cancer Metastatic
- Camrelizumab
- +2 more
-
Chengdu, Sichuan, ChinaSichuan Cancer Hospital & Institute
Jul 21, 2022
Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,
Recruiting
- Gastric Adenocarcinoma
- +4 more
- Capecitabine
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 20, 2022
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (Chemotherapy, Pembrolizumab, Ramucirumab)
Not yet recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Chemotherapy
- +2 more
- (no location specified)
Jan 9, 2023
Solid Tumor Trial in Yantai (NK combined with Chemotherapy, Chemotherapy)
Recruiting
- Solid Tumor
- NK combined with Chemotherapy
- Chemotherapy
-
Yantai, Shandong, ChinaYantai Yuhuangding Hospital
Feb 7, 2022
Solid Tumor Trial in Yantai (DC-CIK combined with Chemotherapy, Chemotherapy)
Recruiting
- Solid Tumor
- DC-CIK combined with Chemotherapy
- Chemotherapy
-
Yantai, Shandong, ChinaYantai Yuhuangding Hospital
Feb 7, 2022
Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)
Recruiting
- Adenocarcinoma
- +8 more
- Radiotherapy targeted to the primary lesion
- +7 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 7, 2023
Recurrent DLBCL, Refractory DLBCL Trial in Houston (Chemotherapy, Computed Tomography, Fludeoxyglucose F-18)
Completed
- Recurrent Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Chemotherapy
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2022
NSCLC Trial (Chemotherapy, Alflutinib plus chemo)
Not yet recruiting
- NSCLC
- Chemotherapy
- Alflutinib plus chemotherapy
- (no location specified)
Jan 25, 2022
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma Trial (drug,
Not yet recruiting
- Anatomic Stage II Breast Cancer AJCC v8
- +3 more
- Chemotherapy
- +4 more
- (no location specified)
Jan 24, 2023
Colorectal Cancer Trial in Hangzhou (Surufatinib, Toripalimab, chemo)
Recruiting
- Colorectal Cancer
- Surufatinib
- +2 more
-
Hangzhou, Zhejiang, ChinaFirst affiliated hospital, Zhejiang University
Feb 26, 2022
Small Cell Lung Cancer Limited Stage Trial (Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy)
Not yet recruiting
- Small Cell Lung Cancer Limited Stage
- Prophylactic cranial irradiation
- +2 more
- (no location specified)
Dec 14, 2022
Rectal Cancer Trial in Mecca (Chemotherapy)
Recruiting
- Rectal Cancer
- Chemotherapy
-
Mecca, Makkah Western, Saudi ArabiaKing Abdullah Medical City, Holy Capital
Apr 5, 2022
Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai
Recruiting
- Esophageal Squamous Cell Carcinoma
- +2 more
- LDRT+CFRT
- +2 more
-
Shanghai, China
- +1 more
Aug 3, 2023
Thoracic Esophageal Squamous Cell Carcinoma Trial in Guangzhou (chemo)
Recruiting
- Thoracic Esophageal Squamous Cell Carcinoma
- chemotherapy
-
Guangzhou, Guangdong, ChinaSun Yat-sen Uniersity Cancer Center
Mar 30, 2022
Drug Toxicity Trial in Rawalpindi (N-Acetylcysteine, Chemotherapy)
Active, not recruiting
- Drug Toxicity
- N-Acetylcysteine
- Chemotherapy
-
Rawalpindi, Punjab, PakistanMedical Oncology department, Fauji Foundation Hospital
Aug 25, 2023
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal
Recruiting
- Rectal Cancer
- Magnetic resonance guided radiotherapy
- Chemotherapy
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 9, 2022
Stage III NSCLC Trial in Birmingham (Adaptive Radiotherapy, Non-Adaptive Radiotherapy, Chemotherapy)
Not yet recruiting
- Stage III Non-small Cell Lung Cancer
- Adaptive Radiotherapy
- +3 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 3, 2022
Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early
Recruiting
- Metastatic Breast Cancer in the Liver
- Chemotherapy
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 23, 2022
Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)
Not yet recruiting
- Stage III Non-small Cell Lung Cancer
- +2 more
- standard Radiotherapy
- +3 more
- (no location specified)
Oct 20, 2023
ctDNA as a Biomarker for Treatment in Advanced NSCLC
Not yet recruiting
- Non-small Cell Lung Cancer
- Immunotherapy
- +2 more
-
Fuzhou, Fujian, China900TH Hospital of Joint Logisti'cs Support Force
Aug 2, 2022
Ovarian Cancer Trial in Tai'an (Bevacizumab, chemo, Fluzoparib)
Recruiting
- Ovarian Cancer
- Bevacizumab
- +2 more
-
Tai'an, Shandong, ChinaThe Second Affiliated Hospital of Shandong First Medical Univers
Dec 24, 2021
Tumor Vaccines for Solid Tumors
Recruiting
- Glioma
- Solid Tumor
- tumor vaccine
- +3 more
-
Shanghai, Shanghai, ChinaHuashan Hospital, Fudan University
Oct 22, 2023
Head and Neck Squamous Cell Carcinoma Trial in Montbéliard (Chemotherapy, Stereotactic radiotherapy)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Chemotherapy
- Stereotactic radiotherapy
-
Montbéliard, FranceHôpital Nord Franche Comté
Mar 10, 2022
Lung Cancer Trial in Germany, Serbia, Switzerland (drug, radiation, procedure)
Active, not recruiting
- Lung Cancer
- Chemotherapy
- +2 more
-
Löwenstein, Germany
- +24 more
Jan 9, 2023